Index of Case Studies

Note: page numbers in italics refer to figures and tables


  • acceptance and commitment therapy (ACT),
  • acoustic neuroma,
  • acute stress disorder, PTSD differential diagnosis,
  • adiposis dolorosa. See Dercum’s disease
  • affect, inappropriate,
  • affective disorder,
  • classical discontinuity hypothesis,
  • symptoms,
  • treatment, . See also schizoaffective disorder
  • aggressive behavior
  • Alzheimer’s disease,
  • conduct disorder,
  • oppositional defiant disorder,
  • pediatric mania, ,
  • schizophrenia and Alzheimer’s disease,
  • alcohol abuse,
  • abstinence goal,
  • ADHD
  • symptoms,
  • treatment,
  • anxiety,
  • and depression,
  • arson,
  • denial, ,
  • with depression,
  • and anxiety,
  • followup,
  • history,
  • outcome,
  • patient intake,
  • driving under the influence,
  • electroconvulsive therapy,
  • goals of treatment,
  • heavy drinking,
  • lack of insight,
  • lying about use,
  • military service, ,
  • psychotherapy,
  • psychotic depression,
  • psychotic sex offender,
  • reduced risk drinking, , ,
  • rehabilitation,
  • relapse, ,
  • treatment-resistant depression,
  • Alcoholics Anonymous (AA),
  • Alzheimer’s disease,
  • aggressive behavior,
  • antipsychotic drug treatment,
  • atypical antipsychotics, , ,
  • cardiovascular disease risk, ,
  • elderly man with schizophrenia,
  • history,
  • outcome,
  • patient intake,
  • history,
  • management,
  • amphetamines
  • with MAO inhibitors,
  • positive urine screen,
  • anorexia nervosa,
  • anti-parkinsonian drugs with antidepressants,
  • anti-tumor necrosis factor (TNF) drugs,
  • anticholinesterase inhibitors,
  • anticonvulsant drugs
  • chronic mental illness, ,
  • mood stabilizing,
  • antidepressant drugs,
  • aggressive,
  • with anti-parkinsonian drugs,
  • antihypertensive treatment combination,
  • anxiety disorder treatment in children,
  • bipolar disorder,
  • response,
  • brain change attenuation, ,
  • indefinite, ,
  • low blood levels, ,
  • Parkinson’s disease with depression,
  • personality disorder,
  • schizophrenia prodrome treatment,
  • treatment-resistant depression,
  • heroic dosing,
  • antipsychotic drugs
  • Alzheimer’s disease patients, ,
  • cardiovascular disease risk, , ,
  • atypical
  • augmentation,
  • complications with diabetes,
  • contraindication in diabetes, ,
  • personality disorder,
  • prescribing in children,
  • social and cognitive decline,
  • cholinesterase inhibitor combination, ,
  • chronic mental illness, ,
  • D2 receptor occupancy,
  • heroic off-label drug use,
  • obesity,
  • pregnancy,
  • response,
  • schizophrenia prodrome treatment,
  • second generation atypical,
  • sexual disorders,
  • typical,
  • antisocial personality disorder, ,
  • anxiety/anxiety disorder
  • alcohol abuse,
  • behavioral desensitization,
  • benzodiazepines,
  • in children,
  • children,
  • outcome and followup,
  • polymorphic disabling,
  • SSRI prescribing,
  • treatment for normal development,
  • cognitive behavioral therapy, ,
  • comorbid ADHD, ,
  • deep brain stimulation,
  • diagnosis,
  • ECT,
  • elderly woman,
  • followup,
  • generalized anxiety disorder, , ,
  • history, ,
  • insomnia,
  • investigations,
  • medications,
  • with narcolepsy,
  • outcome,
  • patient intake,
  • psychiatric evaluation, , , , ,
  • severe generalized,
  • side effects of medications,
  • transcranial magnetic stimulation,
  • treatment-resistant depression, ,
  • vagal nerve stimulation, ,
  • anxiolytics, schizophrenia prodrome treatment,
  • apathy, SSRI-induced,
  • aphasia, treatment-resistant depression,
  • arm postures, abnormal bizarre,
  • arson, ,
  • outcome and followup,
  • Asperger’s syndrome, , ,
  • attention deficit hyperactivity disorder (ADHD),
  • adults
  • rating scales,
  • screening,
  • alcohol abuse,
  • cognitive behavioral therapy, , ,
  • comorbid anxiety, ,
  • comorbid oppositional defiant disorder, , ,
  • diagnosis, ,
  • followup,
  • paediatrician,
  • psychiatric,
  • genetic contribution, ,
  • girls,
  • history, ,
  • inattentive type, ,
  • insomnia, ,
  • misdiagnosis,
  • with oppositional symptoms,
  • outcome,
  • paediatrician evaluation,
  • pediatric mania, ,
  • prefrontal cortex,
  • psychiatric evaluation, ,
  • rating scales,
  • adult,
  • screening of adults,
  • sculpted therapy,
  • sleep hygiene,
  • social and cognitive decline, ,
  • stimulants, , ,
  • symptom checklist,
  • vacations,
  • atypical antipsychotics
  • Alzheimer’s disease, , ,
  • SSRI augmentation, ,
  • autism,
  • phenotype,

  • back injury, military service,
  • back pain, low, ,
  • behavioral desensitization, anxiety disorder,
  • behavioral inhibition, children,
  • behavioral therapy, outpatient,
  • Bell’s palsy,
  • benzodiazepines
  • anxiety disorder treatment,
  • in children,
  • augmentation of antipsychotics,
  • clozapine in psychosis,
  • dyskinesia with schizophrenia,
  • efficacy,
  • panic attacks with depression,
  • high-dose,
  • panic disorder,
  • paranoid schizophrenia,
  • prescribing to children, ,
  • dosage,
  • treatment-resistant psychosis,
  • biofeedback, chronic pain,
  • bipolar disorder, , , , ,
  • antidepressants,
  • childhood-onset,
  • depression with hypertension,
  • diagnosis,
  • dichotomous disease model,
  • family history,
  • followup,
  • forecasting,
  • history, ,
  • with hypomania,
  • identifying,
  • investigations,
  • mixed state,
  • mood instability,
  • mood stabilizer discontinuation,
  • not otherwise specified (NOS), , ,
  • personality disorder symptom overlap,
  • progression,
  • psychiatric evaluation, ,
  • psychotherapy,
  • response to antidepressants,
  • single disease continuum model,
  • substance-induced mood disorder,
  • subtypes,
  • symptoms, ,
  • treatment-resistant,
  • unipolar depression differential diagnosis,
  • bipolar I disorder, ,
  • complaint,
  • diagnosis,
  • followup,
  • history,
  • outcome,
  • treatment history,
  • treatment-resistant mania,
  • bipolar I1/2 disorder,
  • bipolar II disorder, , ,
  • bipolar II1/2 disorder, ,
  • bipolar III disorder, ,
  • bipolar III1/2 disorder,
  • bipolar IV disorder,
  • bipolar V disorder,
  • bipolar VI disorder,
  • bipolar spectrum, ,
  • bipolar spectrum disorder, ,
  • birth control pills,
  • bladder cancer,
  • brain changes
  • in chronic pain,
  • in depression, , . See also traumatic brain injury (TBI)
  • breast cancer, cognitive dysfunction following chemotherapy,
  • breastfeeding, contraindication,

  • cancer
  • depressive episode,
  • panic in cancer survivor,
  • recurrent depression in elderly patient,
  • cannabis. See marijuana
  • Capgras syndrome, ,
  • cardiovascular disease
  • antipsychotic drugs in Alzheimer’s disease, ,
  • depression, ,
  • risk
  • with clozapine, ,
  • with mood stabilizers,
  • with pimozide,
  • with valproate,
  • with venlafaxine, ,
  • transcranial magnetic stimulation, ,
  • cataplexy, diagnostic measures,
  • catechol-O-methyl transferase (COMT), , ,
  • chaos,
  • chemobrain,
  • controversial concept, ,
  • definition,
  • diagnosis,
  • executive dysfunction,
  • followup,
  • incidence,
  • investigations,
  • psychiatric evaluation,
  • specific cognitive defects,
  • chemotherapy for breast cancer, cognitive dysfunction,
  • childhood-onset disorders,
  • followup,
  • history,
  • investigations,
  • psychiatric evaluation,
  • psychotherapy,
  • children
  • anxiety disorder treatment,
  • atypical antipsychotic drug prescribing,
  • behavioral inhibition,
  • benzodiazepine prescribing, , ,
  • dosage,
  • generalized anxiety disorder,
  • pediatric mania,
  • separation anxiety disorder,
  • SSRI prescribing, ,
  • suicide monitoring, , . See also attention deficit hyperactivity disorder (ADHD)
  • cholinesterase inhibitors,
  • combination with antipsychotics,
  • classical discontinuity hypothesis,
  • cognitive behavioral therapy (CBT), , ,
  • ADHD, , ,
  • anxiety, ,
  • chronic pain,
  • obsessive–compulsive disorder,
  • post-traumatic stress disorder,
  • psychotic disorder,
  • cognitive decline,
  • diagnosis,
  • followup,
  • history,
  • investigations,
  • neurological evaluation/neuropsychological testing,
  • outcome,
  • patient intake,
  • psychiatric evaluation,
  • cognitive dysfunction following chemotherapy for breast cancer. See chemobrain
  • cognitive dysfunction following head injury,
  • depression,
  • followup,
  • history,
  • outcome,
  • cognitive function, schizophrenia,
  • cognitive restructuring therapy,
  • colon cancer,
  • combat experience, decompression,
  • conduct disorder, ,
  • features,
  • pediatric mania,
  • confusion, psychotic depression, ,
  • continuous positive airway pressure (CPAP), obstructive sleep apnea,
  • creatinine clearance, drug-induced renal changes,
  • criminal responsibility, insanity, ,
  • Crohn’s disease,
  • cyclothymia with superimposed major depression,
  • cyclothymic temperament,
  • cytochrome P450 drug metabolizing enzymes, , , ,

  • daytime sleepiness, ,
  • deep brain stimulation (DBS), , ,
  • anxiety,
  • treatment-resistant depression, , , ,
  • delusional disorder
  • differential diagnosis,
  • DSM IV,
  • family members with schizophrenia,
  • followup,
  • history,
  • ICD 10,
  • outcome,
  • psychiatric evaluation,
  • delusions,
  • psychosis,
  • history,
  • schizophrenia,
  • substance abuse,
  • dementia
  • early,
  • treatment-resistant depression,
  • depression
  • with alcohol abuse,
  • followup,
  • history,
  • outcome,
  • patient intake,
  • asymptomatic recovery,
  • brain changes, , ,
  • cognitive dysfunction following head injury,
  • diabetes,
  • double,
  • followup,
  • history, , ,
  • hypersomnia,
  • hypertensive patient,
  • outcome,
  • psychiatric evaluation, , ,
  • indefinite treatment of recurrent,
  • kindling hypothesis, ,
  • major, , , ,
  • with cyclothymia,
  • cyclothymic,
  • outcome prediction,
  • progressive, ,
  • recurrent,
  • relapse, ,
  • remission, ,
  • unipolar with anxiety,
  • major depressive episodes,
  • mood fluctuation,
  • diagnosis,
  • psychiatric evaluation,
  • outcome,
  • prediction, ,
  • parkinsonism fluctuation,
  • Parkinson’s disease, ,
  • postpartum,
  • progression,
  • psychiatric evaluation,
  • psychotic,
  • followup,
  • history,
  • outcome,
  • psychiatric evaluation,
  • recurrent in elderly woman,
  • contact reestablishment,
  • diagnosis,
  • followup,
  • history,
  • outcome, ,
  • psychiatric evaluation,
  • quality of life,
  • sustained remission,
  • relapse
  • multiple,
  • prevention,
  • remission,
  • residual symptoms, ,
  • schizoaffective disorder,
  • suicide, ,
  • treatment, ,
  • treatment-resistant, ,
  • anxiety with narcolepsy,
  • atypical antipsychotics,
  • case debrief,
  • experimental protocols,
  • followup, ,
  • history, ,
  • initial psychiatric evaluation,
  • interim followups,
  • investigations,
  • outcome, ,
  • patient intake,
  • psychiatric evaluation, ,
  • psychiatric history,
  • treatments, ,
  • unipolar, , ,
  • with anxiety,
  • bipolar depression differential diagnosis,
  • incidence,
  • major,
  • unstable,
  • vagal nerve stimulation, . See also bipolar disorder
  • depressive recurrent unipolar disorders, major,
  • Dercum’s disease,
  • features,
  • diabetes
  • atypical antipsychotic
  • complications,
  • contraindication, ,
  • clozapine side effect,
  • depression,
  • prediabetes complication of antipsychotics,
  • schizophrenia treatment risks,
  • valproate associated, . See also hyperglycemic hyperosmotic syndrome (HHS)
  • diabetic ketoacidosis (DKA), ,
  • dichotomous disease model,
  • disability litigation,
  • dissociative states,
  • dopamine
  • neurotransmission enhancement, ,
  • overactivity,
  • sensitivity,
  • dopamine D1 receptors, stimulation,
  • dopamine D2 receptors, ,
  • blockade, , ,
  • paranoid schizophrenia,
  • maladaptive effects of antipsychotics,
  • nigrostriatal pathway,
  • occupancy for antipsychotics,
  • driving under the influence,
  • drug dependence therapy, psychotic disorder,
  • drug metabolism, abnormal,
  • drug overdose, anxiety and depression,
  • dyskinesia,
  • with bupropion therapy,
  • dopamine agonist-induced,
  • finger,
  • history, ,
  • neuropsychological evaluation,
  • outcome,
  • prodopaminergic agent-induced,
  • psychiatric evaluation,
  • tongue,
  • worsening, . See also tardive dyskinesia
  • dyslipidemia, ,
  • complications of antipsychotics,
  • psychotic sex offender,
  • schizophrenia treatment risks,
  • dystonia,
  • tardive, ,
  • dopamine D2 receptor blockade,

  • eating disorders, numbness,
  • elderly patients
  • falls,
  • recurrent depression,
  • schizophrenia with Alzheimer’s disease,
  • electroconvulsive therapy (ECT)
  • alcohol abuse,
  • anxiety,
  • aphasia,
  • bipolar I disorder,
  • delusions,
  • depression with diabetes,
  • psychotic depression, ,
  • response to treatment,
  • schizoaffective disorder,
  • treatment-resistant depression,
  • electroencephalogram (EEG), referenced for treatment-resistant depression, ,
  • epidural blocks, chronic pain,
  • Epworth Sleepiness Scale (ESS),
  • executive dysfunction, chemobrain,
  • exposure therapy, post-traumatic stress disorder,
  • extrapyramidal symptoms
  • acute,
  • drug induced,
  • reversible,
  • eye movement desensitization and reprocessing,

  • falls, elderly patient,
  • fibromyalgia, ,
  • fluctuating illness,
  • forensic patients
  • arson,
  • elderly man with schizophrenia and Alzheimer’s disease,
  • psychosis, ,
  • psychotic sex offender,

  • gambling, internet,
  • gastroesophageal reflux disease (GERD),
  • generalized anxiety disorder (GAD),
  • child,
  • comorbid ADHD,
  • comorbid obsessive–compulsive disorder,
  • genetic testing
  • depression,
  • Huntington’s disease,
  • schizophrenia, , , ,
  • genotyping, treatment-resistant depression, ,
  • Glasgow Coma Scale,
  • glutamate, treatment-resistant depression,
  • grandiosity, psychotic sex offender,
  • Gurdjieff, George,

  • hallucinations, ,
  • auditory, , ,
  • command,
  • psychotic depression,
  • head injury, cognitive dysfunction,
  • heavy drinking, . See also alcohol abuse
  • herbal remedies,
  • hip fracture, elderly patient,
  • histrionic personality disorder, , ,
  • homicide,
  • Huntington’s disease, ,
  • hypercholesterolemia, chronic pain patient,
  • hyperglycemic hyperosmotic syndrome (HHS),
  • warning signs/symptoms,
  • hypersomnia,
  • diagnostic measures,
  • primary,
  • hypertension
  • contraindications,
  • depression treatment,
  • MAOIs,
  • potentially lethal combos, ,
  • hyperthermia, MAOI potentially lethal combos, ,
  • hypomania,
  • bipolar disorder,

  • ideas of reference, ,
  • immunosuppressants,
  • impulsivity,
  • insanity, criminal responsibility, ,
  • insomnia
  • ADHD, ,
  • anxiety,
  • cognitive dysfunction following head injury,
  • mania, ,
  • Parkinson’s disease,
  • International Classification of Sleep Disorders,
  • jail sentence, driving under the influence,

  • Kabatt-Zinn, Jon,
  • kindling hypothesis, ,
  • Kraepelinian model,
  • Kraepelinian outcome,

  • Landau Kleffner syndrome,
  • laxatives, abuse,
  • learning disability,
  • social and cognitive decline,
  • leg pain, ,
  • Lewy body dementia,
  • lipomas, multiple painful subcutaneous, , ,
  • low back pain, ,
  • lumbar disc disease, degenerative,
  • lung cancer,

  • major depressive episodes (MDEs),
  • mania
  • adult onset, ,
  • antidepressant-induced,
  • followup,
  • insomnia,
  • management,
  • outcome,
  • pediatric,
  • diagnosis,
  • history,
  • psychiatric evaluation,
  • persistence,
  • postpartum
  • recurrence risk,
  • treatment,
  • pregnancy,
  • prevention,
  • psychiatric evaluation,
  • psychotic break,
  • psychotic depression, ,
  • psychotic sex offender,
  • recurrence,
  • treatment history,
  • treatment-resistant,
  • marijuana
  • depression with mood fluctuations,
  • medical,
  • psychotic disorder, ,
  • memory loss. See chemobrain
  • meningitis,
  • mental illness, chronic,
  • outcome,
  • mentally disordered offender, psychotic sex offender,
  • methylene tetrahydrofolate reductase (MTHFR), ,
  • military service,
  • history,
  • psychiatric disorder incidence,
  • psychiatric evaluation,
  • psychological risk,
  • traumatic brain injury,
  • monoamine oxidase (MAO) enzymes, ,
  • monoamine oxidase inhibitors (MAOIs),
  • with amphetamine actions, ,
  • with amphetamines,
  • approved, ,
  • depression with diabetes,
  • hypertension, ,
  • potentially lethal combos, ,
  • treatment-resistant depression,
  • tyramine dietary modifications, ,
  • mood disorder, ,
  • mixed psychotic disorder,
  • outcome,
  • personality disorder
  • comparison, ,
  • differential diagnosis,
  • prevalence, ,
  • psychiatric evaluation,
  • substance-induced,
  • symptoms, ,
  • mood instability, ,
  • mood stabilizers
  • cardiovascular disease risk,
  • discontinuation,
  • mania treatment,
  • obesity,
  • motivational interviewing,
  • movement disorders
  • drug-induced, ,
  • Parkinson’s disease,
  • permanent,
  • presymptomatic,
  • primary,
  • rapid onset, . See also dyskinesia dystonia tardive dyskinesia
  • mTOR pathway,
  • multiple medical conditions
  • chronic pain patient,
  • recurrent depression,
  • multiple sleep latency test, ,

  • narcissistic personality disorder, ,
  • narcolepsy,
  • classification,
  • diagnostic measures,
  • features,
  • investigations,
  • neuropsychological functioning, ultra high risk of psychosis,
  • neurostimulation therapies. See deep brain stimulation (DBS)
  • nigrostriatal pathway,
  • non-Hodgkin’s lymphoma, ,
  • noncompliance, drug blood levels,
  • norepinephrine,
  • neurotransmission enhancement, ,
  • numbness,
  • eating disorders/substance abuse,
  • nutritional supplements,

  • obesity,
  • chronic pain patient,
  • clozapine side effect,
  • mood stabilizers, ,
  • psychotic sex offender,
  • obsessive–compulsive disorder (OCD),
  • cognitive behavioral therapy,
  • comorbid delusional disorder,
  • comorbid generalized anxiety disorder,
  • deep brain stimulation, ,
  • delusional disorder differential diagnosis,
  • differential diagnosis,
  • evidence-based treatments, ,
  • history,
  • initial evaluation,
  • outcome,
  • serotonergic antidepressants, ,
  • severity improvement,
  • social and cognitive decline,
  • obstructive sleep apnea, , ,
  • chronic pain patient,
  • CPAP use,
  • oculogyric crisis, ,
  • omega 3 fatty acids, schizophrenia prodrome treatment,
  • opiates
  • avoidance of real issues,
  • chronic pain treatment,
  • dependence, ,
  • detoxification program, ,
  • dosage,
  • escalating,
  • reduction, ,
  • overdose, ,
  • somatoform disorders,
  • oppositional behavior,
  • oppositional defiant disorder, ,
  • comorbid ADHD, , ,
  • diagnosis,
  • features,
  • psychiatric evaluation,
  • oppositional symptoms,
  • with ADHD, ,
  • history,
  • paediatrician evaluation,
  • oral contraceptives. See birth control pills

  • P450 drug metabolizing system. See cytochrome P450 drug metabolizing enzymes
  • pain, chronic,
  • brain changes,
  • cause, ,
  • epidural blocks,
  • followup,
  • history,
  • leg,
  • lipomas,
  • low back,
  • outcome,
  • patient intake,
  • psychiatric evaluation,
  • pain disorder,
  • somatoform, ,
  • panic attacks
  • cancer survivor,
  • followup,
  • history,
  • outcome,
  • patient intake,
  • psychiatric evaluation,
  • panic disorder, benzodiazepines,
  • paraphilia,
  • parkinsonism,
  • antipsychotic-induced, , ,
  • reversal,
  • atypical,

  • falls,
  • fluctuation with depression,
  • psychomotor retardation,
  • reversible,
  • Parkinson’s disease, ,
  • depression,
  • falls,
  • followup,
  • movement disorders,
  • outcome,
  • psychiatric evaluation,
  • periodic limb movements, . See also restless legs syndrome
  • persecutory ideation, ,
  • persistent post-concussive syndrome (PPCS),
  • PTSD differential diagnosis, ,
  • traumatic brain injury overlap,
  • personality disorder, ,
  • diagnosis,
  • mood disorder
  • comparison, ,
  • differential diagnosis,
  • mood symptoms, ,
  • outcome,
  • polymorphic mixed,
  • prognosis,
  • psychiatric evaluation,
  • symptoms,
  • pervasive developmental disorder,
  • pharmacodynamic/pharmacokinetic failure,
  • phenotyping, treatment-resistant depression,
  • pituitary adenoma,
  • polypharmacy,
  • polysubstance abuse,
  • post-concussive syndrome,
  • PTSD differential diagnosis, ,
  • post-traumatic stress disorder (PTSD), ,
  • acute stress disorder differential diagnosis,
  • military service,
  • post-concussive syndrome differential diagnosis, ,
  • premorbid childhood onset,
  • psychopharmacologic options,
  • psychotherapy options,
  • risk,
  • traumatic brain injury co-occurrence,
  • postpartum depression,
  • postpartum period,
  • mania treatment,
  • prediabetes, complications of antipsychotics,
  • prefrontal cortex
  • ADHD,
  • head injury,
  • pregnancy
  • antipsychotic drugs,
  • mania,
  • prodromes,
  • psychoanalysis,
  • psychomotor retardation,
  • psychosis,
  • behavioral control in uncooperative patient,
  • classical discontinuity hypothesis,
  • delusions,
  • depression,
  • dichotomous disease model,
  • dyskinesia,
  • long-term, ,
  • malignant,
  • mood disorder,
  • neurocognitive deficits,
  • outcome,
  • partial symptom control on clozapine,
  • patient intake,
  • prodrome,
  • psychiatric evaluation,
  • sex offender,
  • followup,
  • history,
  • outcome,
  • patient intake,
  • single disease continuum model,
  • substance abuse,
  • treatment-resistant, , , , ,
  • ultra high risk, , ,
  • psychotherapy
  • ADHD,
  • alcohol abuse,
  • bipolar disorder,
  • childhood-onset disorders,
  • chronic pain, ,
  • insight oriented,
  • mood disorder,
  • mood instability,
  • opiate dependence,
  • oppositional defiant disorder,
  • personality disorder,
  • post-traumatic stress disorder,
  • refusal by alcoholic,
  • schizophrenia,
  • psychotic disorder spectrum, symptoms,
  • psychotic illness,
  • case debrief,
  • followup visits,
  • history,
  • negative symptoms,
  • patient intake,
  • quality of life, recurrent depression in elderly woman,

  • rapamycin (mTOR) pathway,
  • reduced risk drinking, , ,
  • rehabilitation, alcohol abuse,
  • restless legs syndrome, , ,
  • diagnostic features,
  • with obstructive sleep apnea,
  • rheumatoid arthritis,

  • schizoaffective disorder, ,
  • bipolar type,
  • classical discontinuity hypothesis,
  • diagnosis,
  • dichotomous disease model,
  • followup,
  • long-term,
  • outcome, ,
  • single disease continuum model,
  • substance abuse,
  • treatment,
  • treatment resistant,
  • unremitting psychosis,
  • schizoid personality disorder,
  • schizophrenia, ,
  • childhood-onset,
  • classical discontinuity hypothesis,
  • clinical course,
  • cognitive function, ,
  • diagnosis,
  • dichotomous disease model,
  • differential diagnosis,
  • disorganized type,
  • dyskinesia, ,
  • elderly man with Alzheimer’s disease,
  • history,
  • outcome,
  • patient intake,
  • executive functioning,
  • family members,
  • followup,
  • forecasting,
  • genetics, ,
  • history,
  • investigations,
  • neurocognitive deficits,
  • neurodegenerative basis,
  • outcome, ,
  • paranoid,
  • followup,
  • heroic off-label drug use,
  • history,
  • outcome,
  • treatment, ,
  • prodrome, ,
  • treatment, ,
  • psychiatric evaluation, ,
  • psychotherapy,
  • psychotic break,
  • risks of treatment,
  • single disease continuum model,
  • susceptibility genes,
  • treatment,
  • schizotypal personality disorder,
  • sedation, schizophrenia treatment risks,
  • seeking safety therapy,
  • selective serotonin reuptake inhibitors (SSRIs)
  • apathy,
  • chronic pain,
  • depression with diabetes,
  • efficacy,
  • panic attacks with depression,
  • prescribing to children, ,
  • suicide monitoring, ,
  • self mutilatory behavior, ,
  • personality disorder,
  • separation anxiety disorder,
  • serotonergic antidepressants, obsessive–compulsive disorder,
  • serotonin syndrome, MAOI potentially lethal combos, ,
  • sex offender, psychotic,
  • followup,
  • history,
  • outcome,
  • patient intake,
  • sexual disorder,
  • sexual dysfunction, antidepressant-induced, ,
  • single disease continuum model,
  • single photon emission tomography (SPECT), treatment-resistant depression,
  • sleep disorders
  • classification,
  • Epworth Sleepiness Scale,
  • multiple sleep latency test,
  • psychiatric disorder overlap, . See also obstructive sleep apnea
  • sleep hygiene, ADHD,
  • social anxiety, ,
  • social decline,
  • diagnosis,
  • followup,
  • history,
  • investigations,
  • neurological evaluation/neuropsychological testing,
  • outcome,
  • patient intake,
  • psychiatric evaluation,
  • somatization disorder, ,
  • somatoform disorders, , ,
  • spending, excessive, ,
  • stimulants, ADHD with comorbid anxiety, , ,
  • stress inoculation training, post-traumatic stress disorder,
  • substance abuse
  • alcohol abuse relapse,
  • amphetamines,
  • denial,
  • lack of insight,
  • lying about, ,
  • marijuana smoking,
  • mood disorder,
  • numbness,
  • psychosis with delusions,
  • psychotic disorder,
  • psychotic sex offender,
  • schizoaffective disorder,
  • treatment-resistant depression, . See also alcohol abuse
  • suicide/suicidal ideation
  • alcoholism with depression,
  • depression, ,
  • with mood fluctuations,
  • monitoring in child on SSRIs, ,
  • opiate overdose,
  • paranoid schizophrenia,
  • psychotic depression, ,
  • treatment-resistant depression, ,
  • warnings of risk,
  • symptom fluctuation,

  • tardive dyskinesia, , ,
  • chronic,
  • dopamine D2 receptors,
  • blockade,
  • improvement,
  • irreversible,
  • schizophrenia treatment risks,
  • tardive dystonia, ,
  • dopamine D2 receptor blockade,
  • therapeutic drug monitoring
  • antidepressants, , , ,
  • tinnitus, painful, ,
  • torticollis,
  • drug-induced,
  • transcranial magnetic stimulation (TMS)
  • anxiety,
  • mechanism of action,
  • protocol,
  • repetitive,
  • responsive psychotic depression, , ,
  • results,
  • side effects, ,
  • treatment-resistant depression, , ,
  • traumatic brain injury (TBI),
  • balance loss,
  • cognitive dysfunction,
  • definition,
  • followup,
  • history,
  • incomplete recovery,
  • outcome,
  • persistent post-concussive syndrome,
  • psychiatric evaluation,
  • PTSD
  • co-occurrence,
  • post-concussive syndrome differential diagnosis, ,
  • vestibular symptoms,
  • tyramine, ,
  • dietary modifications, ,
  • vagal nerve stimulation (VNS)
  • anxiety, ,
  • depression,
  • treatment-resistant depression, , ,

  • war zone, decompression,
  • weight gain
  • chronic pain patient,
  • mood stabilizers, ,
  • olanzapine,
  • schizophrenia treatment risks,
  • valproate associated, . See also obesity
  • weight loss, mood stabilizer regime modification,
  • wrist pain, bilateral,
 

Current Prices for Individual Subscribers (prices are subject to change)

  Pay-per-view Subscription (48 hours) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 4th Edition

ISBN: 9780511447990


$ 40
  Annual Subscription (Single User) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 4th Edition

ISBN: 9780511447983


$ 250
  Print + Online Access (One Year, Single User) Unit price

Purchase

Stahl's Essential Psychopharmacology Online

Digital Edition: Print and Online

Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org.

ISBN: 9781107587670


$ 294
For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
online@cambridge.org

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.